Standardised shorter regimens versus individualised longer regimens for rifampin-or multidrug-resistant tuberculosis
We sought to compare the effectiveness of two World Health Organization (WHO)-
recommended regimens for the treatment of rifampin-or multidrug-resistant (RR/MDR) …
recommended regimens for the treatment of rifampin-or multidrug-resistant (RR/MDR) …
[HTML][HTML] Standardised shorter regimens versus individualised longer regimens for rifampin-or multidrug-resistant tuberculosis
S Abidi, J Achar, MMA Neino, D Bang… - European Respiratory …, 2020 - qdcxjkg.com
We sought to compare the effectiveness of two World Health Organization (WHO)-
recommended regimens for the treatment of rifampin-or multidrug-resistant (RR/MDR) …
recommended regimens for the treatment of rifampin-or multidrug-resistant (RR/MDR) …
[PDF][PDF] Standardised shorter regimens versus individualised longer regimens for rifampin-or multidrug-resistant tuberculosis
S Abidi, J Achar, MMA Neino, D Bang… - Eur Respir …, 2020 - api.scienceportal.msf.org
We sought to compare the effectiveness of two World Health Organization (WHO)-
recommended regimens for the treatment of rifampin-or multidrug-resistant (RR/MDR) …
recommended regimens for the treatment of rifampin-or multidrug-resistant (RR/MDR) …
Standardised shorter regimens versus individualised longer regimens for rifampin-or multidrug-resistant tuberculosis
S Abidi, J Achar, AN MM, D Bang… - European …, 2020 - scienceportal.msf.org
We sought to compare the effectiveness of two World Health Organization (WHO)-
recommended regimens for the treatment of rifampin-or multidrug-resistant (RR/MDR) …
recommended regimens for the treatment of rifampin-or multidrug-resistant (RR/MDR) …
Standardised shorter regimens versus individualised longer regimens for rifampin- or multidrug-resistant tuberculosis.
S Abidi, J Achar, MMA Neino, D Bang, A Benedetti… - 2020 - cabidigitallibrary.org
We sought to compare the effectiveness of two World Health Organization (WHO)-
recommended regimens for the treatment of rifampin-or multidrug-resistant (RR/MDR) …
recommended regimens for the treatment of rifampin-or multidrug-resistant (RR/MDR) …
Standardised shorter regimens versus individualised longer regimens for multidrug-resistant TB
S Abidi, J Achar, MMA Neino, D Bang… - European …, 2019 - Eur Respiratory Soc
We sought to compare the effectiveness of two WHO-recommended regimens for the
treatment of rifampin-or multidrug-resistant (RR/MDR) tuberculosis: a standardised regimen …
treatment of rifampin-or multidrug-resistant (RR/MDR) tuberculosis: a standardised regimen …
[引用][C] Standardised shorter regimens versus individualised longer regimens for rifampin-or multidrug-resistant tuberculosis
S Abidi, A Benedetti, JR Campbell, Z Lan… - European Respiratory …, 2020 - elibrary.ru
Standardised shorter regimens versus individualised longer regimens for rifampin-or multidrug-resistant tuberculosis.
S Abidi, J Achar, AN MM, D Bang… - The European …, 2020 - europepmc.org
We sought to compare the effectiveness of two World Health Organization (WHO)-
recommended regimens for the treatment of rifampin-or multidrug-resistant (RR/MDR) …
recommended regimens for the treatment of rifampin-or multidrug-resistant (RR/MDR) …
Standardised shorter regimens versus individualised longer regimens for rifampin-or multidrug-resistant tuberculosis
S Abidi, J Achar, MMA Neino… - The European …, 2020 - pubmed.ncbi.nlm.nih.gov
We sought to compare the effectiveness of two World Health Organization (WHO)-
recommended regimens for the treatment of rifampin-or multidrug-resistant (RR/MDR) …
recommended regimens for the treatment of rifampin-or multidrug-resistant (RR/MDR) …
[PDF][PDF] Standardised shorter regimens versus individualised longer regimens for rifampin-or multidrug-resistant tuberculosis
S Abidi, J Achar, MMA Neino, D Bang… - Eur Respir …, 2020 - scienceportal.msf.org
We sought to compare the effectiveness of two World Health Organization (WHO)-
recommended regimens for the treatment of rifampin-or multidrug-resistant (RR/MDR) …
recommended regimens for the treatment of rifampin-or multidrug-resistant (RR/MDR) …